Insider Buying Report: Dominion Energy and Cryo-Cell International
ByAinvest
Thursday, Aug 28, 2025 11:18 am ET1min read
CCEL--
At Dominion Energy, Robert M. Blue, the Chair, President, and CEO, purchased 4,152 shares of the company's common stock. The purchase was made at a weighted average price of $60.346 per share, totaling $250,556 [1]. This marks the first insider buy by Blue in the past year. Following the transaction, Blue directly owns 161,236 shares and indirectly owns 4,330 shares through a Trustee of Employee Savings Plan. As of Thursday, Dominion Energy's stock was trading flat.
Meanwhile, David Portnoy, Chairman and Co-CEO of Cryo-Cell International, purchased 39,179 shares of the company's stock for $176,198 [2]. This buy was made at a cost of $4.50 per share. Portnoy's latest acquisition is the second purchase in the past year, following two previous buys totaling $109,383 at an average of $4.35 per share. Cryo-Cell International's stock was trading up by 8.2% on Thursday.
These insider buying activities suggest a positive outlook from the executives on the future performance of their respective companies. However, it is essential for investors to consider these transactions in the broader context of the companies' financial health and market conditions.
References:
[1] https://www.tradingview.com/news/tradingview:45e49912cd889:0-dominion-energy-s-ceo-robert-m-blue-buys-company-shares/
[2] https://www.nasdaq.com/articles/thursday-8-28-insider-buying-report-d-ccel
D--
Dominion Energy CEO Robert M. Blue bought 4,152 shares of D for $250,557, while Chairman, Co-CEO David Portnoy purchased 39,179 shares of Cryo-Cell International for $176,198. Both transactions occurred on Wednesday, with Dominion Energy trading flat and Cryo-Cell International up 8.2% on Thursday. These purchases mark the first and second buys by Blue and Portnoy, respectively, in the past year.
On Wednesday, August 27, 2025, significant insider buying activity was reported at two prominent companies: Dominion Energy and Cryo-Cell International. The transactions highlight the confidence of top executives in their respective companies' prospects.At Dominion Energy, Robert M. Blue, the Chair, President, and CEO, purchased 4,152 shares of the company's common stock. The purchase was made at a weighted average price of $60.346 per share, totaling $250,556 [1]. This marks the first insider buy by Blue in the past year. Following the transaction, Blue directly owns 161,236 shares and indirectly owns 4,330 shares through a Trustee of Employee Savings Plan. As of Thursday, Dominion Energy's stock was trading flat.
Meanwhile, David Portnoy, Chairman and Co-CEO of Cryo-Cell International, purchased 39,179 shares of the company's stock for $176,198 [2]. This buy was made at a cost of $4.50 per share. Portnoy's latest acquisition is the second purchase in the past year, following two previous buys totaling $109,383 at an average of $4.35 per share. Cryo-Cell International's stock was trading up by 8.2% on Thursday.
These insider buying activities suggest a positive outlook from the executives on the future performance of their respective companies. However, it is essential for investors to consider these transactions in the broader context of the companies' financial health and market conditions.
References:
[1] https://www.tradingview.com/news/tradingview:45e49912cd889:0-dominion-energy-s-ceo-robert-m-blue-buys-company-shares/
[2] https://www.nasdaq.com/articles/thursday-8-28-insider-buying-report-d-ccel

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet